This inventor holds 1 USPTO granted patent. Top assignee: Forschungszentrum Julich Gmbh. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Marcus Frings
Introduction
Marcus Frings is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target bromodomains. His work is crucial in the fight against disorders associated with these domains, including cancer.
Latest Patents
Marcus Frings holds a patent for bromodomain inhibitors. This invention relates to compounds according to the general formula (1) and their use in the production of a medicament, especially for treating disorders associated with bromodomains, such as cancer. He has 1 patent to his name.
Career Highlights
Frings is currently employed at Forschungszentrum Jülich GmbH, a prominent research center in Germany. His role involves extensive research and development in the field of medicinal compounds, contributing to advancements in therapeutic options for various diseases.
Collaborations
Throughout his career, Marcus has collaborated with several talented individuals, including Bianca Altenburg and Steffen Koschmieder. These collaborations have enhanced the research output and innovation in their respective fields.
Conclusion
Marcus Frings is a dedicated inventor whose work in bromodomain inhibitors showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against cancer and other related disorders.